Prevalence of CCR5 and CCR2 HIV-coreceptor gene polymorphisms in Belgium

Human Heredity

Volumn 50, Issue 5, 2000, Pages 304-307

  Struyf, Frank ^a   Thoelen, Inge ^a   Charlier, Nathalie ^a   Keyaerts, Els ^a   Van Der Donck, Ingrid ^a   Wuu, Joanne ^b   Van Ranst, Marc ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Acquired immunodeficiency syndrome; Belgium; CCR2; CCR5; Chemokine receptors; HIV; Polymorphism

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BELGIUM; DNA POLYMORPHISM; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; VIRUS PATHOGENESIS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0034095703     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022932     Document Type: Article

References (13)

1. Liu R, Paxton WA, Choe S, Ceradini D, Martin SR, Horuk R, MacDonald ME, Stuhlmann H, Koup RA, Landau NR: Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996;86:367-377.
2. Smith MW, Dean M, Carrington M, Winkler C, Huttley GA, Lomb DA, Goedert JJ, O'Brien TR, Jacobson LP, Kaslow R, Buchbinder S, Vittinghoff E, Vlahov D, Hoots K, Hilgartner MW, Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study, O'Brien SJ: Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-965.
3. Magierowska M, Theodorou I, Debré P, Sanson F, Autran B, Rivière Y, Charron D, French ALT and IMMUNOCO Study Groups, Costagliola D: Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 1999;93:936-941.
4. Martin MP, Dean M, Smith MW, Winkler C, Gerrard B, Michael NL, Lee B, Doms RW, Margolick J, Buchbinder S, Goedert JJ, O'Brien TR, Hilgartner MW, Vlahov D, O'Brien SJ, Carrington M: Genetic acceleration of AIDS progression by a promoter variant of CCR5. Science 1998;282:1907-1911.
5. Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB: Global distribution of the CCR5 gene 32-basepair deletion. Nature Genet 1997; 16:100-103.
6. Libert F, Cochaux P, Beckman G, Samson M, Aksenova M, Cao A, Czeizel A, Claustres M, de la Rua C, Ferrari M, Ferrec C, Glover G, Grinde B, Guran S, Kucinskas V, Lavinha J, Mercier B, Ogur G, Peltonen L, Rosatelli C, Schwartz M, Spitsyn V, Timar L, Beckman L, Parmentier M, Vassart G: The ACCR5 mutation conferring protection against HIV-1 in Caucasian populations has a single and recent origin in Northeastern Europe. Hum Mol Genet 1998;7:399-406.
7. Lench N, Stanier P, Williamson R: Simple non-invasive method to obtain DNA for gene analysis. Lancet 1988;i:1356-1358.
8. de Roda Husman AM, Koot M, Cornelissen M, Keet IP, Brouwer M, Broersen SM, Bakker M, Roos MT, Prins M, de Wolf F, Coutinho RA, Miedema F, Goudsmit J, Schuitemaker H: Association between CCR5 genotype and the clinical course of HIV-1 infection. Ann Intern Med 1997;127:882-890.
9. Schneiders, Küffer JM, Roessli D, Excoffier L: Arlequin: Software for population genetic data analysis version 1.1. Genetics and Biometry Lab, Dept. of Anthropology, University of Geneva, 1997.
10. Slatkin M, Excoffier L: Testing for linkage disequilibrium in genotypic data using the Expectation-Maximization algorithm. Heredity 1996;76:377-383.
11. Samson M, Libert F, Doranz BJ, Rucker J, Liesnard C, Farber CM, Saragosti S, Lapoumeroulie C, Cognaux J, Forceille C, Muyldermans G, Verhofstede C, Burtonboy G, Georges M, Imai T, Rana S, Yi Y, Smyth RJ, Collman RG, Doms RW, Vassart G, Parmentier M: Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR5 chemokine receptor gene. Nature 1996;382:722-725.
12. Kostrikis LG, Huang Y, Moore JP, Wolinsky SM, Zhang L, Guo Y, Deutsch L, Phair J, Neumann AU, Ho DD: A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nat Med 1998;4:350-353.
13. Mariani R, Wong S, Mulder LCF, Wilkinson DA, Reinhart AL, LaRosa G, Nibbs R, O'Brien TR, Michael NL, Connor RI, MacDonald M, Busch M, Koup RA, Landau NR: CCR2-641 polymorphism is not associated with altered CCR5 expression or coreceptor function. J Virol 1999;73:2450-2459.